COVID-19 Antibody Test

Coronavirus Today

 / May 28th, 2023

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Coronavirus Breaking News

Apr 27 • 2:15 pm CDT

COVID-19 Cases Continue Decreasing in Most Countries

The World Health Organization (WHO) today published Edition #140 of its Weekly epidemiological update on the COVID-19 pandemic. As of April 27, 2023, the WHO confirmed nearly 2.8 million new COVID-19 cases, and over 16,000 related... READ →
Apr 27 • 10:44 am CDT

COVID-19 Antiviral Sales Decrease 88%

Merck today announced financial results for the first quarter of 2023. In addition, Merck stated it realized lower sales of the oral COVID-19 antiviral Lagevrio™ (Molnupiravir), which decreased 88% to $392 million. This decrease was primarily... READ →
Apr 25 • 2:21 pm CDT

Lagevrio Reduces Severe COVID-19 Risk

The BMJ today published a study based on U.S. VA data that concluded among people at high risk of progression to severe COVID-19-19, molnupiravir ( Lagevrio™ ) use within five days of SARS-CoV-2 virus infection may... READ →
Apr 25 • 11:21 am CDT

U.S. FDA Cleared COVID-19 Monoclonal Antibody Candidate's Application

Invivyd, Inc. today announced that the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for VYD222, a monoclonal antibody (mAb) candidate. Invivyd is developing VYD222 to prevent COVID-19 in vulnerable... READ →
Apr 25 • 10:51 am CDT

Investigational COVID-19 Oral Antiviral Granted Fast Track Status

Atea Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration granted Fast Track designation to bemnifosbuvir for treating COVID-19. Bemnifosbuvir (AT-527) is an oral, direct-acting antiviral drug candidate, a nucleotide polymerase inhibitor that targets... READ →

More Coronavirus Breaking News

COVID-19 Vaccine Immune Imprinting Confirmed

Later COVID-19 Waves Saw a Decrease in Severe Outcomes

41 Million At-Home SARS-CoV-2 Virus Tests Completed

COVID-19 Cases Resurge in India

Long-Acting Antibody Candidate Neutralizes COVID-19 Variants

Pharmacies Lead COVID-19 Vaccinations

Which State Managed COVID-19 Best

Universal Masking... A Strategy Whose Time Has Come and Gone, For Now

National COVID-19 Preparedness Plan Announced in the U.S.

COVID-19 Vaccination Can Clear this Coronavirus

Latest Coronavirus Breaking News

SARS-CoV-2 antibody therapy SARS-CoV-2 Antibody Therapy Delivered Strong Protection Against Severe COVID-19 Amubarvimab and romlusevimab combination found effective against COVID-19
  • COVID-19
FDA Bivalent mRNA COVID-19 Vaccines Become Simplified US FDA expands Bivalent mRNA COVID-19 Vaccine authorizations
  • COVID-19
COVID-19 vaccinations April 14, 2023 Immune Imprinting Risk Following COVID-19 Vaccination Reported COVID-19 vaccine original antigenic sin risk identified
  • COVID-19
Women pregnant vaccines 2023 Pregnant Women Have Vaccination Concerns Annenberg Science and Public Health Knowledge Monitor Spring 2023
COVID-19 research Real-World Data Reveals COVID-19 Treatment Efficacy COVID-19 monoclonal antibody treatments found safe and effective
COVID-19 antivirals The Case of Repurposing Antivirals for COVID-19 Drug repurposing based on observational clinical studies
Vaccine recommendations March 2023 WHO Needs COVID-19 Vaccination COVID-19 vaccination guidance updated in March 2023
Virus variant definitions The WHO Better Defines SARS-CoV-2 Variants Multiple coronavirus variants of concern and variants of interest have been designated
Face mask research March 2023 Face Mask Review Being Reviewed Cochrane Review face mask analysis
Airline virus screening Airplanes Can Detect COVID-19 International Traveler Based Genomic Surveillance Program
COVID-19 immunity Natural Immunity Also Protects People from COVID-19 SARS-CoV-2 infection protects against virus re-infection
Emergency Use Authorization Emergency Access Continues Post COVID-19 Pandemic U.S. FDA COVID-19 EUAs will remain effective
SARS-CoV-2 virus protection Calculate Your COVID-19 Immunity Hybrid immunity produced 42% lower chance of severe COVID-19
COVID-19 vaccinations UK England Preps COVID-19 Plans for Fall JCVI interim recommendations on the COVID-19 vaccination for 2023
Heart disease and COVID-19 Heart Disease and COVID-19 Don't Mix 2023 Report From the American Heart Association
Free coronavirus tests 2023 Free COVID-19 Testing Easy to Find
Face mask reduces coronavirus spreading Masking Returns as COVID-19 Departs
Vaccine safety study Vaccine Safety Signal for Seniors Preliminary Identified
Long covid discussion How Short is Long COVID
Vaccine decisions Are You Vaccine Hesitant
COVID-19 antibody therapy Does Evusheld Protect People Against XBB.1.5
Free home test for virus Once Again, Free COVID-19 Home Tests
oral antiviral Oral Antiviral Use Reduces COVID-19 Risk
Coronavirus Vaccine Effectiveness Analyzed Against Long COVID-19
Copenhagen harbor Denmark Further Reduces Access to COVID-19 Vaccines
keyboard with yes no Are Monoclonal Antibodies Beneficial for Hospitalised COVID-19 Patients?
2022 calendar with covid sign Omicron BA.x Subvariants Better at Evading Most COVID-19 Therapeutics
high school basketball game players Paxlovid Rebound Cases Confirmed by CDC
The White House Long COVID Becomes National Priority
blood donation COVID-19 Convalescent Plasma Found Very Effective When Administered Early
glass windows in a building Let’s Clear the Air on Spreading COVID-19
girl giving her dad a high five Coronavirus Infected Children Display Strong Antibody Protection
mink face Coronavirus Infected Animals Can Facilitate New Variants
high tech digital gear Achieving Techquity Will Change the Next Pandemic
men in hard hats and masks having a meeting U.S. Employers Required to Enforce COVID-19 Vaccinations or Testing

For more articles, try our search.